{"title":"The Relationship of In-Hospital Mortality with Cardiac Injury in COVID-19 Patients: A Retrospective Cohort Study","authors":"Sevil Gülaştı, Ferdi Gülaştı","doi":"10.5336/cardiosci.2022-93884","DOIUrl":null,"url":null,"abstract":"Objective: Coronavirus disease-2019 (COVID-19) emerged in late 2019 and has caused a pandemic, resulting in significant morbidity and mortality. However, the clinical significance of cardiac injury in patients affected by COVID-19 is still unknown. Therefore, our objective was to explore the association between cardiac injury and mortality in hospitalized patients with COVID-19. Material(s) and Method(s): The study included four hundred forty-three patients with laboratory values for troponin and follow-up. The mean age was 57.3+/-16.0 years. The male to female ratio was 1.53. Fever (45.6%) and cough (42.7%) were the most frequent sign and symptom at admission. Hypertension was the most common comorbidity, identified in 140 patients (31.6%). Result(s): In 143 (32.2%) patients, we determined cardiac injury. The median length of hospital stay was ten days. The mortality rate was 14.4%. The median length of hospital stay was longer in patients with cardiac injury (14 days vs. 9 days, respectively) (p<0.001). The mortality rate was 3.7% in the patients without cardiac injury, whereas the mortality rate was significantly higher among the patients with cardiac injury (37.7%, p<0.001). The multivariable model showed that cardiac injury was the only independent risk factor for death. There was a higher risk of death in patients with cardiac injury than in those without cardiac injury [hazard ratio, 4.01 (95% confidence interval, 1.85-8.72, p<0.001)]. Conclusion(s): In conclusion, cardiac injury is a common condition among hospitalized patients with COVID-19 and is associated with an elevated risk of in-hospital mortality. In addition, it is significantly more common in patients with known heart disease, complicating the treatment process.Copyright © 2022 by Turkiye Klinikleri.","PeriodicalId":39118,"journal":{"name":"Turkiye Klinikleri Cardiovascular Sciences","volume":"136 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Turkiye Klinikleri Cardiovascular Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5336/cardiosci.2022-93884","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
COVID-19患者住院死亡率与心脏损伤的关系:一项回顾性队列研究
目的:2019冠状病毒病(COVID-19)于2019年底出现,并已引起大流行,发病率和死亡率很高。然而,COVID-19患者心脏损伤的临床意义尚不清楚。因此,我们的目的是探讨COVID-19住院患者心脏损伤与死亡率之间的关系。材料和方法:本研究纳入了443例肌钙蛋白化验值及随访的患者。平均年龄为57.3±16.0岁。男女比例为1.53。发热(45.6%)和咳嗽(42.7%)是入院时最常见的体征和症状。高血压是最常见的合并症,140例(31.6%)。结果:143例(32.2%)患者确定心脏损伤。住院时间中位数为10天。死亡率为14.4%。心脏损伤患者的中位住院时间更长(分别为14天和9天)(p<0.001)。无心脏损伤组的死亡率为3.7%,有心脏损伤组的死亡率为37.7%,p<0.001。多变量模型显示,心脏损伤是死亡的唯一独立危险因素。心脏损伤患者的死亡风险高于无心脏损伤患者[风险比为4.01(95%可信区间为1.85 ~ 8.72,p<0.001)]。结论:总之,心脏损伤是COVID-19住院患者的常见病,并与院内死亡风险升高相关。此外,它在已知心脏病患者中更为常见,使治疗过程复杂化。Turkiye Klinikleri版权所有©2022。
本文章由计算机程序翻译,如有差异,请以英文原文为准。